Regeneron
09.13.18
FDA to Review Eylea (Aflibercept) Injection for the Treatment of Diabetic RetinopathySource: Regeneron Pharmaceuticals
08.17.18
FDA Approves 12-Week Dosing for Eylea in Wet AMD PatientsSource: Regeneron Pharmaceuticals
08.14.18
Regeneron Faces Delay to FDA Approval of 12-Week Dosing Schedule for Eylea in Wet AMDSource: FirstWord